热门资讯> 正文
BioNTech GAAP每股收益为-1.60欧元，收入为2.608亿欧元
2025-08-04 18:47
- BioNTech press release (NASDAQ:BNTX): Q2 GAAP EPS of -€1.60.
- Revenue of €260.8M (+102.6% Y/Y).
- Revenues for the 2025 financial year €1,700 million - €2,200 million
More on BioNTech
- BioNTech: More Uncertainty Emerges
- BioNTech's Acquisition Of CureVac Brings Complementary Method To Target Cancer
- Bristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better Investment
- BioNTech Q2 2025 Earnings Preview
- Experts helping vaccine advisors are reportedly ousted at CDC
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
